The CHIP-clinic as the catalyst of preventive medicine

Clonal Hematopoiesis of Indeterminate Potential (CHIP) is associated with an increased risk of cardiovascular diseases (CVD) and is a precursor stage to the BCR-ABL negative chronic myeloproliferative neoplasms (MPNs). These diseases are acquired stem cell neoplasms, arising due to mutations in the...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hans Carl Hasselbalch, Vibe Skov, Lasse Kjaer, Trine Alma Knudsen, Christina Schjellerup Eickhardt-Dalbøge, Christina Ellervik, Sabrina Cordua, Anders Lindholm Sørensen, Sarah Friis Christensen, Marie Hvelplund Kristiansen, Jes Sanddal Lindholt, Mads Thomassen, Torben A. Kruse, Niels Eske Bruun, Matias Greve Lindholm, Claus Henrik Nielsen, Miklos Egyed, Winfried März, Morten Kranker Larsen, Troels Wienecke
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-10-01
Series:	Frontiers in Hematology
Subjects:	JAK2V617F mutation cardiovascular disease stroke myeloproliferative neoplasms (MPNs) CHIP-clinic preventative medicine
Online Access:	https://www.frontiersin.org/articles/10.3389/frhem.2024.1459154/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

The CHIP-clinic as the catalyst of preventive medicine

Similar Items